Hemrajani Rekha 4/A
4/A · BioAge Labs, Inc. · Filed Mar 10, 2025
Insider Transaction Report
Form 4/AAmended
Hemrajani Rekha
Director
Transactions
- Purchase
Common Stock
2024-09-27$18.00/sh+3,000$54,000→ 3,000 total
Footnotes (1)
- [F1]The reported securities were purchased through a directed share program in connection with the Issuer's initial public offering.